BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12833899)

  • 1. Research oversight through new lenses: the consortium to examine clinical research ethics.
    Sugarman J; Eckenwiler LA; Emanuel EJ
    IRB; 2003; 25(1):9-10. PubMed ID: 12833899
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based practice of research ethics review?
    Beagan B; McDonald M
    Health Law Rev; 2005; 13(2-3):62-8. PubMed ID: 16459416
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of OHRP compliance oversight letters.
    Borror K; Carome M; McNeilly P; Weil C
    IRB; 2003; 25(5):1-4. PubMed ID: 14870724
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 6. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
    Maloney DM
    Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
    [No Abstract]   [Full Text] [Related]  

  • 7. SACHRP recommendations for review of children's research requiring DHHS secretary's approval.
    Fisher CB; Kornetsky SZ
    IRB; 2005; 27(3):8-10. PubMed ID: 16021795
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond compliance...is it too much to ask?
    Koski G
    IRB; 2003; 25(5):5-6. PubMed ID: 14870726
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
    Mann H; Shamoo AE
    Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
    [No Abstract]   [Full Text] [Related]  

  • 10. Professional responsibility and the protection of human subjects of research in Canada.
    Dinsdale H
    Health Law Rev; 2005; 13(2-3):80-5. PubMed ID: 16459419
    [No Abstract]   [Full Text] [Related]  

  • 11. The task for ethics review: should research ethics boards address an approach or a paradigm?
    Nelson CH; McPherson DH
    NCEHR Commun; 2004; 12(2):11-22. PubMed ID: 15460563
    [No Abstract]   [Full Text] [Related]  

  • 12. Rules of the game: institutional review boards.
    Lubowitz JH; Poehling GG; Burkhart SS
    Arthroscopy; 2008 Apr; 24(4):373-4. PubMed ID: 18375265
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of requirements of research ethics committees in 11 European countries for a non-invasive interventional study.
    Hearnshaw H
    BMJ; 2004 Jan; 328(7432):140-1. PubMed ID: 14726341
    [No Abstract]   [Full Text] [Related]  

  • 14. Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.
    Lingler JH; Parker LS; DeKosky ST; Schulz R
    IRB; 2006; 28(3):11-8. PubMed ID: 17036439
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection of health research participants in the United States: a review of two cases.
    Douglass A; Crampton P
    N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
    Fitzgerald DW; Wasunna A; Pape JW
    IRB; 2003; 25(2):14-8. PubMed ID: 12833903
    [No Abstract]   [Full Text] [Related]  

  • 17. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

  • 18. Accreditation and certification for human research protection programs.
    Maloney DM
    Hum Res Rep; 2001 Nov; 16(11):1-2. PubMed ID: 11883458
    [No Abstract]   [Full Text] [Related]  

  • 19. The conduct of Canadian researchers and institutional review boards regarding substituted consent for research.
    Bravo G; Dubois MF; Paquet M
    IRB; 2004; 26(1):1-8. PubMed ID: 15281211
    [No Abstract]   [Full Text] [Related]  

  • 20. Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research compliance.
    Kelly PA; Johnson ML
    IRB; 2005; 27(2):6-10. PubMed ID: 15948325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.